Modular manufacturing: The key to unlocking mRNA expansion?
The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the industry seeks to refine and futureproof its models of production, modular manufacturing is emerging as a key solution.
